Skip to main content
. 2018 May 28;33(1):989–998. doi: 10.1080/14756366.2018.1474878

Table 3.

% inhibitory effect of the compounds on kinase activities.

Compd No. % inhibition of 10 μM
EGFR HER2 HER4 cSrc
Staurosporinea 94 81 100 100
2b 0 1 5 4
3b 0 0 3 3
6a 6 1 5 5
7a 0 0 4 1
7b 1 0 3 3
8a 6 0 10 4

aStaurosporine used in 1 μM concentration.